|
1
|
Johnell O and Kanis JA: An estimate of the
worldwide prevalence and disability associated with osteoporotic
fractures. Osteoporos Int. 17:1726–1733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cumming RG, Nevitt MC and Cummings SR:
Epidemiology of hip fractures. Epidemiol Rev. 19:244–257. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leibson CL, Tosteson AN, Gabriel SE,
Ransom JE and Melton LJ III: Mortality, disability, and nursing
home use for persons with and without hip fracture: A
population-based study. J Am Geriatr Soc. 50:1644–1650. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hofbauer LC, Hamann C and Ebeling PR:
Approach to the patient with secondary osteoporosis. Eur J
Endocrinol. 162:1009–1020. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bernstein CN, Leslie WD and Leboff MS: AGA
technical review on osteoporosis in gastrointestinal diseases.
Gastroenterology. 124:795–841. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Staa TP, Geusens P, Bijlsma JW,
Leufkens HG and Cooper C: Clinical assessment of the long-term risk
of fracture in patients with rheumatoid arthritis. Arthritis Rheum.
54:3104–3112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Melton LJ III, Kyle RA, Achenbach SJ,
Oberg AL and Rajkumar SV: Fracture risk with multiple myeloma: A
population-based study. J Bone Miner Res. 20:487–493. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarasin C: Osteomalacie und hypochrome
anaemie nach magenresektion. Gastroenterologia. 66:182–197. 1941.
View Article : Google Scholar
|
|
9
|
Klinge B, Lehto-Axtelius D, Akerman M and
Håkanson R: Structure of calvaria after gastrectomy. An
experimental study in the rat. Scand J Gastroenterol. 30:952–957.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lehto-Axtelius D, Surve VV, Johnell O and
Håkanson R: Effects of calcium deficiency and calcium
supplementation on gastrectomy-induced osteopenia in the young male
rat. Scand J Gastroenterol. 37:299–306. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Axelson J, Persson P, Gagnemo-Persson R
and Håkanson R: Importance of the stomach in maintaining calcium
homoeostasis in the rat. Gut. 32:1298–1302. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Persson P, Gagnemo-Persson R, Chen D,
Axelson J, Nylander AG, Johnell O and Häkanson R: Gastrectomy
causes bone loss in the rat: Is lack of gastric acid responsible?
Scand J Gastroenterol. 28:301–306. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mühlbauer RC, Schenk RK, Chen D,
Lehto-Axtelius D and Hâkanson R: Morphometric analysis of
gastrectomy-evoked osteopenia. Calcif Tissue Int. 62:323–326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Targownik LE, Lix LM, Metge CJ, Prior HJ,
Leung S and Leslie WD: Use of proton pump inhibitors and risk of
osteoporosis-related fractures. CMAJ. 179:319–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chonan O, Takahashi R, Yasui H and
Watanuki M: Effect of L-lactic acid on calcium absorption in rats
fed omeprazole. J Nutr Sci Vitaminol (Tokyo). 44:473–481. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Connell MB, Madden DM, Murray AM, Heaney
RP and Kerzner LJ: Effects of proton pump inhibitors on calcium
carbonate absorption in women: A randomized crossover trial. Am J
Med. 118:778–781. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tuukkanen J and Väänänen HK: Omeprazole, a
specific inhibitor of H+-K+-ATPase, inhibits bone resorption in
vitro. Calcif Tissue Int. 38:123–125. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizunashi K, Furukawa Y, Katano K and Abe
K: Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone
resorption in humans. Calcif Tissue Int. 53:21–25. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin JM, Cho YM and Sachs G: Chemistry of
covalent inhibition of the gastric (H+, K+)-ATPase by proton pump
inhibitors. J Am Chem Soc. 126:7800–7811. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sachs G, Shin JM, Vagin O, Lambrecht N,
Yakubov I and Munson K: The gastric H,K ATPase as a drug target:
Past, present, and future. J Clin Gastroenterol. 41(Suppl 2):
S226–S242. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saitoh T, Fukushima Y, Otsuka H, Hirakawa
J, Mori H, Asano T, Ishikawa T, Katsube T, Ogawa K and Ohkawa S:
Effects of rabeprazole, lansoprazole and omeprazole on intragastric
pH in CYP2C19 extensive metabolizers. Aliment Pharmacol Ther.
16:1811–1817. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohta T, Hashimoto T, Murai H and Kimura H:
Influence of proton pump inhibitor on bone metabolism marker. J N
Rem Clin. 57:1341–1345. 2008.
|
|
23
|
Kawai T, Ikeda H, Harada Y and Saitou T:
Changes in the rat stomach after long-term administration of proton
pump inhibitors (AG-1749 and E-3810). Nihon Rinsho. 50:188–193.
1992.(In Japanese). PubMed/NCBI
|
|
24
|
Miyashita T, Shah FA, Marti GP, Wang J,
Bonde P, Gibson MK, Ohta T, Montgomery EA, Duncan M and Harmon JW:
Rabeprazole impedes the development of reflux-induced esophageal
cancer in a surgical rat model. Dig Dis Sci. 56:1309–1314. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Savarino V, Di Mario F and Scarpignato C:
Proton pump inhibitors in GORD An overview of their pharmacology,
efficacy and safety. Pharmacol Res. 59:135–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jacobson BC, Ferris TG, Shea TL, Mahlis
EM, Lee TH and Wang TC: Who is using chronic acid suppression
therapy and why? Am J Gastroenterol. 98:51–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang YX, Lewis JD, Epstein S and Metz DC:
Long-term proton pump inhibitor therapy and risk of hip fracture.
JAMA. 296:2947–2953. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vestergaard P, Rejnmark L and Mosekilde L:
Proton pump inhibitors, histamine H2 receptor antagonists, and
other antacid medications and the risk of fracture. Calcif Tissue
Int. 79:76–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Vries F, Cooper AL, Cockle SM, van Staa
TP and Cooper C: Fracture risk in patients receiving
acid-suppressant medication alone and in combination with
bisphosphonates. Osteoporos Int. 20:1989–1998. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu EW, Blackwell T, Ensrud KE, Hillier TA,
Lane NE, Orwoll E and Bauer DC: Acid-suppressive medications and
risk of bone loss and fracture in older adults. Calcif Tissue Int.
83:251–259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roux C, Briot K, Gossec L, Kolta S, Blenk
T, Felsenberg D, Reid DM, Eastell R and Glüer CC: Increase in
vertebral fracture risk in postmenopausal women using omeprazole.
Calcif Tissue Int. 84:13–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hansen KE, Jones AN, Lindstrom MJ, Davis
LA, Ziegler TE, Penniston KL, Alvig AL and Shafer MM: Do proton
pump inhibitors decrease calcium absorption? J Bone Miner Res.
25:2786–2795. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karsdal MA, Henriksen K, Sørensen MG, Gram
J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin
TJ, Christiansen C, et al: Acidification of the osteoclastic
resorption compartment provides insight into the coupling of bone
formation to bone resorption. Am J Pathol. 166:467–476. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Niikura K, Takeshita N and Takano M: A
vacuolar ATPase inhibitor, FR167356, prevents bone resorption in
ovariectomized rats with high potency and specificity: Potential
for clinical application. J Bone Miner Res. 20:1579–1588. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sheraly AR, Lickorish D, Sarraf F and
Davies JE: Use of gastrointestinal proton pump inhibitors to
regulate osteoclast-mediated resorption of calcium phosphate
cements in vivo. Curr Drug Deliv. 6:192–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Iwamoto J, Sato Y and Matsumoto H:
Influence of gastrectomy on cortical and cancellous bones in rats.
Gastroenterol Res Pract. 2013:3816162013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Someya S, Shibata C, Tanaka N, Kudoh K,
Naitoh T, Miura K and Unno M: Duodenal switch for intractable
reflux gastroesophagitis after proximal gastrectomy. Tohoku J Exp
Med. 230:129–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Imada T, Rino Y, Takahashi M, Suzuki M,
Tanaka J, Shiozawa M, Kabara K, Hatori S, Ito H, Yamamoto Y, et al:
Postoperative functional evaluation of pylorus-preserving
gastrectomy for early gastric cancer compared with conventional
distal gastrectomy. Surgery. 123:165–170. 1998. View Article : Google Scholar : PubMed/NCBI
|
